With reduced IL‐1β activity, there is less tumor-derived IL-1β and IL-6 activity on bone marrow cells and ultimately decreased STAT3 activity in this cell population (Figure 5), supporting our previous findings that tumor-NLRP3 activity induces IL-1β and IL-6 in the bone marrow (16). Here, STAT3 is linked to neoplasm.